世界の前立腺がん治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Prostate Cancer Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4830 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、前立腺がん治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（医薬品、医療機器）、用途別市場規模（病院薬局、ドラッグストア、オンライン販売）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・前立腺がん治療薬の市場動向 ・企業の競争状況、市場シェア ・前立腺がん治療薬の種類別市場規模（医薬品、医療機器） ・前立腺がん治療薬の用途別市場規模（病院薬局、ドラッグストア、オンライン販売） ・前立腺がん治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・前立腺がん治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・前立腺がん治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・前立腺がん治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・前立腺がん治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Sanofi、Pfizer、Amgen、Johnson & Johnson、AstraZeneca、AbbVie、Bayer、Ipsen Group、Endo Pharmaceuticals、Dendreon Corporation (Sanpower Group Co. Ltd.)） ・結論

Market Analysis and Insights: Global Prostate Cancer Therapeutics Market
The global Prostate Cancer Therapeutics market size is projected to reach US$ 9677.3 million by 2026, from US$ 7420 million in 2019, at a CAGR of 3.8% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Prostate Cancer Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Prostate Cancer Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Prostate Cancer Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Prostate Cancer Therapeutics market.

Global Prostate Cancer Therapeutics Scope and Market Size
Prostate Cancer Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Prostate Cancer Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Drugs
Medical Devices

Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Sales

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sanofi
Pfizer
Amgen
Johnson & Johnson
AstraZeneca
AbbVie
Bayer
Ipsen Group
Endo Pharmaceuticals

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Cancer Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drugs
1.2.3 Medical Devices
1.3 Market by Application
1.3.1 Global Prostate Cancer Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Sales
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Prostate Cancer Therapeutics Market Perspective (2016-2027)
2.2 Prostate Cancer Therapeutics Growth Trends by Regions
2.2.1 Prostate Cancer Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Prostate Cancer Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Prostate Cancer Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Prostate Cancer Therapeutics Industry Dynamic
2.3.1 Prostate Cancer Therapeutics Market Trends
2.3.2 Prostate Cancer Therapeutics Market Drivers
2.3.3 Prostate Cancer Therapeutics Market Challenges
2.3.4 Prostate Cancer Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Therapeutics Players by Revenue
3.1.1 Global Top Prostate Cancer Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Prostate Cancer Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Prostate Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Prostate Cancer Therapeutics Revenue
3.4 Global Prostate Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Prostate Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Therapeutics Revenue in 2020
3.5 Prostate Cancer Therapeutics Key Players Head office and Area Served
3.6 Key Players Prostate Cancer Therapeutics Product Solution and Service
3.7 Date of Enter into Prostate Cancer Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate Cancer Therapeutics Breakdown Data by Type
4.1 Global Prostate Cancer Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Prostate Cancer Therapeutics Forecasted Market Size by Type (2022-2027)

5 Prostate Cancer Therapeutics Breakdown Data by Application
5.1 Global Prostate Cancer Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Prostate Cancer Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Prostate Cancer Therapeutics Market Size (2016-2027)
6.2 North America Prostate Cancer Therapeutics Market Size by Type
6.2.1 North America Prostate Cancer Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Prostate Cancer Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Prostate Cancer Therapeutics Market Size by Type (2016-2027)
6.3 North America Prostate Cancer Therapeutics Market Size by Application
6.3.1 North America Prostate Cancer Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Prostate Cancer Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Prostate Cancer Therapeutics Market Size by Application (2016-2027)
6.4 North America Prostate Cancer Therapeutics Market Size by Country
6.4.1 North America Prostate Cancer Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Prostate Cancer Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Prostate Cancer Therapeutics Market Size (2016-2027)
7.2 Europe Prostate Cancer Therapeutics Market Size by Type
7.2.1 Europe Prostate Cancer Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Prostate Cancer Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Prostate Cancer Therapeutics Market Size by Type (2016-2027)
7.3 Europe Prostate Cancer Therapeutics Market Size by Application
7.3.1 Europe Prostate Cancer Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Prostate Cancer Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Prostate Cancer Therapeutics Market Size by Application (2016-2027)
7.4 Europe Prostate Cancer Therapeutics Market Size by Country
7.4.1 Europe Prostate Cancer Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Prostate Cancer Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Prostate Cancer Therapeutics Market Size by Type
8.2.1 Asia-Pacific Prostate Cancer Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Prostate Cancer Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Prostate Cancer Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Prostate Cancer Therapeutics Market Size by Application
8.3.1 Asia-Pacific Prostate Cancer Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Prostate Cancer Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Prostate Cancer Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Prostate Cancer Therapeutics Market Size by Region
8.4.1 Asia-Pacific Prostate Cancer Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Prostate Cancer Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Prostate Cancer Therapeutics Market Size (2016-2027)
9.2 Latin America Prostate Cancer Therapeutics Market Size by Type
9.2.1 Latin America Prostate Cancer Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Prostate Cancer Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Prostate Cancer Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Prostate Cancer Therapeutics Market Size by Application
9.3.1 Latin America Prostate Cancer Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Prostate Cancer Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Prostate Cancer Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Prostate Cancer Therapeutics Market Size by Country
9.4.1 Latin America Prostate Cancer Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Prostate Cancer Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Prostate Cancer Therapeutics Market Size by Type
10.2.1 Middle East & Africa Prostate Cancer Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Prostate Cancer Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Prostate Cancer Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Prostate Cancer Therapeutics Market Size by Application
10.3.1 Middle East & Africa Prostate Cancer Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Prostate Cancer Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Prostate Cancer Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Prostate Cancer Therapeutics Market Size by Country
10.4.1 Middle East & Africa Prostate Cancer Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Prostate Cancer Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Prostate Cancer Therapeutics Introduction
11.1.4 Sanofi Revenue in Prostate Cancer Therapeutics Business (2016-2021)
11.1.5 Sanofi Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Prostate Cancer Therapeutics Introduction
11.2.4 Pfizer Revenue in Prostate Cancer Therapeutics Business (2016-2021)
11.2.5 Pfizer Recent Development
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen Prostate Cancer Therapeutics Introduction
11.3.4 Amgen Revenue in Prostate Cancer Therapeutics Business (2016-2021)
11.3.5 Amgen Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Prostate Cancer Therapeutics Introduction
11.4.4 Johnson & Johnson Revenue in Prostate Cancer Therapeutics Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Details
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Prostate Cancer Therapeutics Introduction
11.5.4 AstraZeneca Revenue in Prostate Cancer Therapeutics Business (2016-2021)
11.5.5 AstraZeneca Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Prostate Cancer Therapeutics Introduction
11.6.4 AbbVie Revenue in Prostate Cancer Therapeutics Business (2016-2021)
11.6.5 AbbVie Recent Development
11.7 Bayer
11.7.1 Bayer Company Details
11.7.2 Bayer Business Overview
11.7.3 Bayer Prostate Cancer Therapeutics Introduction
11.7.4 Bayer Revenue in Prostate Cancer Therapeutics Business (2016-2021)
11.7.5 Bayer Recent Development
11.8 Ipsen Group
11.8.1 Ipsen Group Company Details
11.8.2 Ipsen Group Business Overview
11.8.3 Ipsen Group Prostate Cancer Therapeutics Introduction
11.8.4 Ipsen Group Revenue in Prostate Cancer Therapeutics Business (2016-2021)
11.8.5 Ipsen Group Recent Development
11.9 Endo Pharmaceuticals
11.9.1 Endo Pharmaceuticals Company Details
11.9.2 Endo Pharmaceuticals Business Overview
11.9.3 Endo Pharmaceuticals Prostate Cancer Therapeutics Introduction
11.9.4 Endo Pharmaceuticals Revenue in Prostate Cancer Therapeutics Business (2016-2021)
11.9.5 Endo Pharmaceuticals Recent Development
11.10 Dendreon Corporation (Sanpower Group Co. Ltd.)
11.10.1 Dendreon Corporation (Sanpower Group Co. Ltd.) Company Details
11.10.2 Dendreon Corporation (Sanpower Group Co. Ltd.) Business Overview
11.10.3 Dendreon Corporation (Sanpower Group Co. Ltd.) Prostate Cancer Therapeutics Introduction
11.10.4 Dendreon Corporation (Sanpower Group Co. Ltd.) Revenue in Prostate Cancer Therapeutics Business (2016-2021)
11.10.5 Dendreon Corporation (Sanpower Group Co. Ltd.) Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Prostate Cancer Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Drugs
Table 3. Key Players of Medical Devices
Table 4. Global Prostate Cancer Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Prostate Cancer Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Prostate Cancer Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Prostate Cancer Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Prostate Cancer Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Prostate Cancer Therapeutics Market Share by Regions (2022-2027)
Table 10. Prostate Cancer Therapeutics Market Trends
Table 11. Prostate Cancer Therapeutics Market Drivers
Table 12. Prostate Cancer Therapeutics Market Challenges
Table 13. Prostate Cancer Therapeutics Market Restraints
Table 14. Global Prostate Cancer Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Prostate Cancer Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Prostate Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Therapeutics as of 2020)
Table 17. Ranking of Global Top Prostate Cancer Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Prostate Cancer Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Prostate Cancer Therapeutics Product Solution and Service
Table 21. Date of Enter into Prostate Cancer Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Prostate Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Prostate Cancer Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Prostate Cancer Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Prostate Cancer Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Prostate Cancer Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Prostate Cancer Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Prostate Cancer Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Prostate Cancer Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Prostate Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Prostate Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Prostate Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Prostate Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Prostate Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Prostate Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Prostate Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Prostate Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Prostate Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Prostate Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Prostate Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Prostate Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Prostate Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Prostate Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Prostate Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Prostate Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Prostate Cancer Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Prostate Cancer Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Prostate Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Prostate Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Prostate Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Prostate Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Prostate Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Prostate Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Prostate Cancer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Prostate Cancer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Prostate Cancer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Prostate Cancer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Prostate Cancer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Prostate Cancer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Sanofi Company Details
Table 62. Sanofi Business Overview
Table 63. Sanofi Prostate Cancer Therapeutics Product
Table 64. Sanofi Revenue in Prostate Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 65. Sanofi Recent Development
Table 66. Pfizer Company Details
Table 67. Pfizer Business Overview
Table 68. Pfizer Prostate Cancer Therapeutics Product
Table 69. Pfizer Revenue in Prostate Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Pfizer Recent Development
Table 71. Amgen Company Details
Table 72. Amgen Business Overview
Table 73. Amgen Prostate Cancer Therapeutics Product
Table 74. Amgen Revenue in Prostate Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Amgen Recent Development
Table 76. Johnson & Johnson Company Details
Table 77. Johnson & Johnson Business Overview
Table 78. Johnson & Johnson Prostate Cancer Therapeutics Product
Table 79. Johnson & Johnson Revenue in Prostate Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Johnson & Johnson Recent Development
Table 81. AstraZeneca Company Details
Table 82. AstraZeneca Business Overview
Table 83. AstraZeneca Prostate Cancer Therapeutics Product
Table 84. AstraZeneca Revenue in Prostate Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 85. AstraZeneca Recent Development
Table 86. AbbVie Company Details
Table 87. AbbVie Business Overview
Table 88. AbbVie Prostate Cancer Therapeutics Product
Table 89. AbbVie Revenue in Prostate Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 90. AbbVie Recent Development
Table 91. Bayer Company Details
Table 92. Bayer Business Overview
Table 93. Bayer Prostate Cancer Therapeutics Product
Table 94. Bayer Revenue in Prostate Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Bayer Recent Development
Table 96. Ipsen Group Company Details
Table 97. Ipsen Group Business Overview
Table 98. Ipsen Group Revenue in Prostate Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Ipsen Group Recent Development
Table 100. Endo Pharmaceuticals Company Details
Table 101. Endo Pharmaceuticals Business Overview
Table 102. Endo Pharmaceuticals Prostate Cancer Therapeutics Product
Table 103. Endo Pharmaceuticals Revenue in Prostate Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 104. Endo Pharmaceuticals Recent Development
Table 105. Dendreon Corporation (Sanpower Group Co. Ltd.) Company Details
Table 106. Dendreon Corporation (Sanpower Group Co. Ltd.) Business Overview
Table 107. Dendreon Corporation (Sanpower Group Co. Ltd.) Prostate Cancer Therapeutics Product
Table 108. Dendreon Corporation (Sanpower Group Co. Ltd.) Revenue in Prostate Cancer Therapeutics Business (2016-2021) & (US$ Million)
Table 109. Dendreon Corporation (Sanpower Group Co. Ltd.) Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Drugs Features
Figure 3. Medical Devices Features
Figure 4. Global Prostate Cancer Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Hospital Pharmacy Case Studies
Figure 6. Retail Pharmacy Case Studies
Figure 7. Online Sales Case Studies
Figure 8. Prostate Cancer Therapeutics Report Years Considered
Figure 9. Global Prostate Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Prostate Cancer Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Prostate Cancer Therapeutics Market Share by Regions: 2020 VS 2027
Figure 12. Global Prostate Cancer Therapeutics Market Share by Regions (2022-2027)
Figure 13. Global Prostate Cancer Therapeutics Market Share by Players in 2020
Figure 14. Global Top Prostate Cancer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Therapeutics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Prostate Cancer Therapeutics Revenue in 2020
Figure 16. Global Prostate Cancer Therapeutics Revenue Market Share by Type (2016-2021)
Figure 17. Global Prostate Cancer Therapeutics Revenue Market Share by Type (2022-2027)
Figure 18. North America Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Prostate Cancer Therapeutics Market Share by Type (2016-2027)
Figure 20. North America Prostate Cancer Therapeutics Market Share by Application (2016-2027)
Figure 21. North America Prostate Cancer Therapeutics Market Share by Country (2016-2027)
Figure 22. United States Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Prostate Cancer Therapeutics Market Share by Type (2016-2027)
Figure 26. Europe Prostate Cancer Therapeutics Market Share by Application (2016-2027)
Figure 27. Europe Prostate Cancer Therapeutics Market Share by Country (2016-2027)
Figure 28. Germany Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Prostate Cancer Therapeutics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Prostate Cancer Therapeutics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Prostate Cancer Therapeutics Market Share by Region (2016-2027)
Figure 38. China Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Prostate Cancer Therapeutics Market Share by Type (2016-2027)
Figure 46. Latin America Prostate Cancer Therapeutics Market Share by Application (2016-2027)
Figure 47. Latin America Prostate Cancer Therapeutics Market Share by Country (2016-2027)
Figure 48. Mexico Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Prostate Cancer Therapeutics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Prostate Cancer Therapeutics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Prostate Cancer Therapeutics Market Share by Country (2016-2027)
Figure 54. Turkey Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Prostate Cancer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Sanofi Revenue Growth Rate in Prostate Cancer Therapeutics Business (2016-2021)
Figure 58. Pfizer Revenue Growth Rate in Prostate Cancer Therapeutics Business (2016-2021)
Figure 59. Amgen Revenue Growth Rate in Prostate Cancer Therapeutics Business (2016-2021)
Figure 60. Johnson & Johnson Revenue Growth Rate in Prostate Cancer Therapeutics Business (2016-2021)
Figure 61. AstraZeneca Revenue Growth Rate in Prostate Cancer Therapeutics Business (2016-2021)
Figure 62. AbbVie Revenue Growth Rate in Prostate Cancer Therapeutics Business (2016-2021)
Figure 63. Bayer Revenue Growth Rate in Prostate Cancer Therapeutics Business (2016-2021)
Figure 64. Ipsen Group Revenue Growth Rate in Prostate Cancer Therapeutics Business (2016-2021)
Figure 65. Endo Pharmaceuticals Revenue Growth Rate in Prostate Cancer Therapeutics Business (2016-2021)
Figure 66. Dendreon Corporation (Sanpower Group Co. Ltd.) Revenue Growth Rate in Prostate Cancer Therapeutics Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---